MétaCan
Menu
← Back to cohort
Record W4409624454 · doi:10.1158/1538-7445.am2025-3681

Abstract 3681: A tumor-naive method for estimating tumor fraction using 5-hydroxymethylation cytosine in cell-free DNA

2025· article· en· W4409624454 on OpenAlexaff
Ceyda Çoruh, Onur Sakarya, Yuhong Ning, Yuan Xue, Michael J. Cipriano, Kyle Hazen, Alexander W. Wyatt, David A. Quigley, Felix Y. Feng, Martin Sjöström, Gulfem D. Guler, Wayne Volkmuth, Samuel Levy

Bibliographic record

VenueCancer Research · 2025
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicMolecular Biology Techniques and Applications
Canadian institutionsUniversity of British Columbia
Fundersnot available
KeywordsCytosineDNAFraction (chemistry)Molecular biologyBiologyChemistryGeneticsCancer researchChromatography

Abstract

fetched live from OpenAlex

Abstract Accurate measurement of the tumor fraction (TF) in circulating cell-free DNA (cfDNA) allows estimation of tumor burden non-invasively, potentially useful in guiding treatment decisions, monitoring treatment response, and detecting minimal residual disease. 5-hydroxymethylation of cytosine (5hmC) marks activation of cancer drivers and downstream gene targets, and has been shown to positively correlate with gene expression and gene regulation. Here we trained a machine learning (ML) model to predict TF in a tumor-naive way from 5hmC-enriched sequencing data together with low-pass whole genome sequencing data. In cross-validation the ML model showed excellent performance, showing high correlation (R > 0.8) and low composite absolute error (CAE < 5%) compared to copy-number variation (CNV) based estimates. The high correlation was confirmed in an independent test set which also showed R > 0.8, with only a modest increase in CAE (<10%) using targeted point mutation-based TF estimates as an external reference comparator. Using in silico cancer mixtures that created contrived cfDNA samples targeting concentrations below 10%, our 5hmC-based TF prediction method achieved detection sensitivity of approximately 90% with a specificity of 97%. Finally, we observed that 5hmC-based predicted TF was significantly associated with overall survival (HR = 1.04, p < 0.001) in an independent prostate patient cfDNA cohort when controlling for other covariates. In summary, we find that the 5hmC-based TF estimate is a reliable metric of tumor burden irrespective of tumor mutational status. The 5hmC-based TF estimate may be used either alone or in conjunction with mutation and CNV-based estimates to provide more accurate measures of survival risk and therapy response during treatment. Citation Format: Ceyda Coruh, Onur Sakarya, Yuhong Ning, Yuan Xue, Michael Cipriano, Kyle Hazen, Alexander W. Wyatt, David Quigley, Felix Feng, Martin Sjostrom, Gulfem Guler, Wayne Volkmuth, Samuel Levy. A tumor-naive method for estimating tumor fraction using 5-hydroxymethylation cytosine in cell-free DNA [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2025; Part 1 (Regular Abstracts); 2025 Apr 25-30; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2025;85(8_Suppl_1):Abstract nr 3681.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.002
metaresearch head score (Gemma)0.004
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: none
GenreCandidate signal: Other · Consensus signal: none
Teacher disagreement score0.006
Threshold uncertainty score0.012

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0020.004
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0010.000
Science and technology studies0.0000.000
Scholarly communication0.0010.001
Open science0.0010.001
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0030.002

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.049
GPT teacher head0.452
Teacher spread0.403 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreOther

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueCancer Research→Same topicMolecular Biology Techniques and Applications→French-language works237,207→